Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

Merck To Develop Anti-Staph Antibodies To Intercell Target

May 17, 2006

By Cormac Sheridan

Dutch Consortium Preparing National Push In Biomedicals

May 17, 2006

By Cormac Sheridan

With GMP Manufacturing Ready, Austrianova Plans Pivotal Trial

May 17, 2006

By Cormac Sheridan

With GMP Manufacturing Ready, Austrianova Plans Pivotal Trial

May 17, 2006

By Cormac Sheridan

Dutch Consortium Preparing National Push In Biomedicals

May 17, 2006

By Cormac Sheridan

Merck To Develop Anti-Staph Antibodies To Intercell Target

May 17, 2006

By Cormac Sheridan

Berna Biotech's Spinout Kenta Raises CHF10M For Antibodies

May 10, 2006

By Cormac Sheridan

BioPartners Second To Gain EU OK For Generic Biologic

May 10, 2006

By Cormac Sheridan

Borean Out-Licensing Apo A-I Atherosclerosis Drug To Roche

May 10, 2006

By Cormac Sheridan

BioPartners Second To Gain EU OK For Generic Biologic

May 10, 2006

By Cormac Sheridan

View All Articles by Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...